Buys
Open market- Shares
- +758,574
- Avg price
- $26.37
- Total value
- +$19,999,979
Deep Track Biotechnology Master Fund, Ltd. - 10%+ Owner at LB PHARMACEUTICALS INC
Issuer-level insider activity
- Role
- 10%+ Owner
- Issuer ticker
- LBRX on Nasdaq
- Entity type
- Company
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Deep Track Biotechnology Master Fund, Ltd. in LB PHARMACEUTICALS INC
Sells
Open market- Shares
- Avg price
- Total value
Net
Past year- Shares
- +758,574
- Share %
- 100%
- Total value
- +$19,999,979
Reported holdings for Deep Track Biotechnology Master Fund, Ltd. in LB PHARMACEUTICALS INC
Form 4 holding
10%+ Owner
LB PHARMACEUTICALS INC
- Security class
- Pre-Funded Warrants (Right to Buy)
- Shares / value
- 664,649
- Estimated value
- $23,222,769
- Report date
- 30 Jul 2026
- Price
- $34.94
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
10%+ Owner
LB PHARMACEUTICALS INC
- Security class
- Pre-Funded Warrants (Right to Buy)
- Shares / value
- 664,649
- Estimated value
- $23,222,769
- Report date
- 30 Jul 2026
- Price
- $34.94
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
10%+ Owner
LB PHARMACEUTICALS INC
- Security class
- Pre-Funded Warrants (Right to Buy)
- Shares / value
- 664,649
- Estimated value
- $23,222,769
- Report date
- 30 Jul 2026
- Price
- $34.94
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
10%+ Owner
LB PHARMACEUTICALS INC
- Security class
- Pre-Funded Warrants (Right to Buy)
- Shares / value
- 93,925
- Estimated value
- $1,988,382
- Report date
- 30 Jul 2026
- Price
- $21.17
- Ownership
- By Deep Track Special Opportunities Fund, LP
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
10%+ Owner
LB PHARMACEUTICALS INC
- Security class
- Common Stock
- Shares / value
- 2,686,138
- Estimated value
- Report date
- 12 Sep 2025
- Price
- Ownership
- Direct
Form 4 holding
10%+ Owner
LB PHARMACEUTICALS INC
- Security class
- Common Stock
- Shares / value
- 666,666
- Estimated value
- Report date
- 12 Sep 2025
- Price
- Ownership
- By Deep Track Special Opportunities Fund, LP
Form 4 holding
10%+ Owner
LB PHARMACEUTICALS INC
- Security class
- Pre-Funded Warrants (Right to Buy)
- Shares / value
- 93,925
- Estimated value
- Report date
- 30 Jul 2026
- Price
- Ownership
- By Deep Track Special Opportunities Fund, LP
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
10%+ Owner
LB PHARMACEUTICALS INC
- Security class
- Pre-Funded Warrants (Right to Buy)
- Shares / value
- 93,925
- Estimated value
- Report date
- 30 Jul 2026
- Price
- Ownership
- By Deep Track Special Opportunities Fund, LP
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
10%+ Owner
LB PHARMACEUTICALS INC
- Security class
- Series C Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 12 Sep 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Deep Track Biotechnology Master Fund, Ltd. in LB PHARMACEUTICALS INC
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.